Erik Walldén

Erik Walldén is currently the Chairman & President of Wallden Associates at Mr. Walldén AB. He is also the Chairman of Lumicks BV, Director at Affibody AB, Director at SymCel AB, Director at Beactica Therapeutics AB, and Director at Cellseed Sweden AB. In the past, Mr. Walldén served as the President & Chief Executive Officer of Biacore International AB from 1989 to 2006.
He was also the President & Chief Executive Officer of Gyros AB from 2009 to 2013 and the Chief Executive Officer of Biotage AB. Additionally, he held positions such as President & Chief Executive Officer of Affibody Medical AB, Chairman of Genovis AB, Deputy Chairman-Supervisory Board of Exiqon A, Chairman of AroCell AB, and Chairman of SwedenBIO Service AB. He served as a Director at VisEn Medical, Inc. and Healthinvest Partners AB, as well as a Non-Executive Director at Tecan Group AG from 2011 to 2015.
He also served as a Director at Fastighets Ab Briggen, Proxeon Biosystems ApS, and Proxeon Bioinformatics A. Mr. Walldén obtained his undergraduate degree from the University of Uppsala.